Education
About Us
Working with TipRanks
Follow Us
Kestra Medical Technologies Ltd. (KMTS)
:KMTS
Total Valuation
Kestra Medical Technologies Ltd. has a market cap or net worth of $847.25M. The enterprise value is $1.12B.
Market Cap$847.25M
Enterprise Value$1.12B
Share Statistics
Kestra Medical Technologies Ltd. has 51,348,656 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding51,348,656
Owned by Insiders―
Owned by Institutions70.56%
Financial Efficiency
Kestra Medical Technologies Ltd.’s return on equity (ROE) is 0.45 and return on invested capital (ROIC) is -655.61%.
Return on Equity (ROE)0.45
Return on Assets (ROA)-2.05
Return on Invested Capital (ROIC)-655.61%
Return on Capital Employed (ROCE)-6.55
Revenue Per Employee92.71K
Profits Per Employee-313.73K
Employee Count300
Asset Turnover0.61
Inventory Turnover8.34
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio―
PS Ratio0.00
PB Ratio-5.17
Price to Fair Value-5.17
Price to FCF-12.76
Price to Operating Cash Flow-14.98
PEG Ratio-0.69
Income Statement
In the last 12 months, Kestra Medical Technologies Ltd. had revenue of 27.81M and earned -94.12M in profits. Earnings per share was -2.04.
Revenue27.81M
Gross Profit362.00K
Operating Income-85.06M
Pretax Income-94.10M
Net Income-94.12M
EBITDA-76.31M
Earnings Per Share (EPS)-2.04
Cash Flow
In the last 12 months, operating cash flow was -33.33M and capital expenditures -8.26M, giving a free cash flow of -41.60M billion.
Operating Cash Flow-33.33M
Free Cash Flow-41.60M
Free Cash Flow per Share-0.81
Dividends & Yields
Kestra Medical Technologies Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.81
52-Week Price Change-21.39%
50-Day Moving Average17.99
200-Day Moving Average―
Relative Strength Index (RSI)47.85
Average Volume (3m)488.76K
Important Dates
Kestra Medical Technologies Ltd. upcoming earnings date is Apr 20, 2026, After Close (Confirmed).
Last Earnings DateJul 15, 2025
Next Earnings DateApr 20, 2026
Ex-Dividend Date―
Financial Position
Kestra Medical Technologies Ltd. as a current ratio of 0.45, with Debt / Equity ratio of -21.57%
Current Ratio0.45
Quick Ratio0.35
Debt to Market Cap0.04
Net Debt to EBITDA-0.48
Interest Coverage Ratio-13.65
Taxes
In the past 12 months, Kestra Medical Technologies Ltd. has paid 24.00K in taxes.
Income Tax24.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Kestra Medical Technologies Ltd. EV to EBITDA ratio is -14.66, with an EV/FCF ratio of -13.20.
EV to Sales40.22
EV to EBITDA-14.66
EV to Free Cash Flow-13.20
EV to Operating Cash Flow-15.49
Balance Sheet
Kestra Medical Technologies Ltd. has $54.35M in cash and marketable securities with $46.61M in debt, giving a net cash position of -$7.74M billion.
Cash & Marketable Securities$54.35M
Total Debt$46.61M
Net Cash-$7.74M
Net Cash Per Share-$0.15
Tangible Book Value Per Share-$4.23
Margins
Gross margin is 1.30%, with operating margin of -305.83%, and net profit margin of -338.39%.
Gross Margin1.30%
Operating Margin-305.83%
Pretax Margin-338.30%
Net Profit Margin-338.39%
EBITDA Margin-274.34%
EBIT Margin-315.91%
Analyst Forecast
The average price target for Kestra Medical Technologies Ltd. is $26.40, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$26.40
Price Target Upside60.00% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast―
EPS Growth Forecast―